D. Mark
Clinical Research Institute
Department of Medicine
Duke University Medical Center
Durham
USA
Name/email consistency: high
- Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]. Mark, D.B., Cowper, P.A., Berkowitz, S.D., Davidson-Ray, L., DeLong, E.R., Turpie, A.G., Califf, R.M., Weatherley, B., Cohen, M. Circulation (1998)
- When innovative therapies make economic sense: economic analysis of enoxaparin versus unfractionated heparin in the ESSENCE trial--an overview. Efficacy and Safety of Subcutaneous in non-Q Wave Coronary Events. Mark, D. Can. J. Cardiol (1998)